References
  1. https://coronavirus.jhu.edu/map.html 05.16.2020
  2. Varma N, Michalski J, Epstein AE, et al. Automatic remote monitoring of implantable cardioverter- defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ Arrhythm Electrophysiol 2010;3:428–36.
  3. Guedon-Moreau L, Chevalier P, Marquie C, et al. Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J 2010;31:2246–52.
  4. Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010;122:325–32.
  5. Capucci A, Santini M, Padeletti L, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913–20.
  6. Boehmer JP, Hariharan R, Devecchi FG, et al. A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study. JACC Heart Fail. 2017 Mar;5(3):216-225.
  7. Forleo GB, Tesauro M, Panattoni G, et al. Impact of Continuous Intracardiac ST-segment Monitoring on Mid-Term Outcomes of ICD-implanted Patients With Coronary Artery Disease. Early Results of a Prospective Comparison With Conventional ICD Outcomes. Heart. 2012 Mar;98(5):402-7.
  8. Forleo GB, Panattoni G, Schirripa V, et al. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system. J Cardiovasc Med, 14(10),726–732.
  9. Boehmer JP, Hariharan R, Devecchi FG, et al. A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study. JACC Heart Fail. 2017 Mar;5(3):216-225.
  10. Della Rocca DG, Albanese M, Placidi F, et al. Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording. J Interv Card Electrophysiol. 2019 Dec;56(3):327-333.
  11. Lakkireddy DR, Chung MK, et al. Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19). Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. HeartRhythm 2020.
  12. Ricci RP, Morichelli L. Workflow, time and patient satisfaction from the perspectives of Home Monitoring. Europace (2013)15,i49–i53.
  13. Spitzer RL, Kroenke K, Williams JBW, Löwe B. (2006). A Brief Measure for Assessing Generalized Anxiety Disorder. Archives of Internal Medicine, 166(10),1092.
  14. Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 2014;384:583–590.
  15. Crossley GH. Further evidence that remote monitoring is cost-effective: it’s time for all to adopt. HeartRhytm 2017;14:58.
  16. Artico J, Zecchin M, Zorzin Fantasia A, et al. Long-term Patient Satisfaction With Implanted Device Remote Monitoring: A Comparison Among Different Systems. J Cardiovasc Med 2019 Aug;20(8):542-550.
  17. De Filippo O, D’Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med.